{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:48:19Z","timestamp":1793144899727,"version":"4.5.0"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,10]]},"abstract":"<jats:sec>\n            <jats:title>Objectives:<\/jats:title>\n            <jats:p>To examine the performance of the urinary biomarker panel tissue inhibitor of metalloproteinase-2 and insulin-like growth factor-binding protein 7 in patients with sepsis at ICU admission. To investigate the effect of nonrenal organ dysfunction on tissue inhibitor of metalloproteinase-2 and insulin-like growth factor-binding protein 7 in this population.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Method:<\/jats:title>\n            <jats:p>In this ancillary analysis, we included patients with sepsis who were enrolled in either of two trials including 39 ICUs across Europe and North America. The primary endpoint was moderate-severe acute kidney injury (equivalent to Kidney Disease Improving Global Outcome stage 2\u20133) within 12 hours of enrollment. We assessed biomarker performance by calculating the area under the receiver operating characteristic curve, sensitivity, specificity, and negative and positive predictive values at three cutoffs: 0.3, 1.0, and 2.0 (ng\/mL)<jats:sup>2<\/jats:sup>\/1,000. We also calculated nonrenal Sequential Organ Failure Assessment scores for each patient on enrollment and compared tissue inhibitor of metalloproteinase-2 and insulin-like growth factor-binding protein 7 results in patients with and without acute kidney injury and across nonrenal Sequential Organ Failure Assessment scores. Finally, we constructed a clinical model for acute kidney injury in this population and compared the performance of the model with and without tissue inhibitor of metalloproteinase-2 and insulin-like growth factor-binding protein 7.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>We included 232 patients in the analysis and 40 (17%) developed acute kidney injury. We observed significantly higher urine tissue inhibitor of metalloproteinase-2 and insulin-like growth factor-binding protein 7 in patients with acute kidney injury than without acute kidney injury in both patients with low and high nonrenal Sequential Organ Failure Assessment scores (<jats:italic toggle=\"yes\">p<\/jats:italic> &lt; 0.001). The area under the receiver operating characteristic curve (95% CI) of tissue inhibitor of metalloproteinase-2 and insulin-like growth factor-binding protein 7 was 0.84 (0.73\u20130.92) and 0.85 (0.76\u20130.94), in low and high nonrenal Sequential Organ Failure Assessment score subgroups. Performance of the tissue inhibitor of metalloproteinase-2 and insulin-like growth factor-binding protein 7 test was not modified by nonrenal Sequential Organ Failure Assessment (<jats:italic toggle=\"yes\">p<\/jats:italic> = 0.70). In multivariate analysis, the addition of tissue inhibitor of metalloproteinase-2 and insulin-like growth factor-binding protein 7 significantly improved the performance of a clinical model for predicting acute kidney injury (<jats:italic toggle=\"yes\">p<\/jats:italic> = 0.015).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Urinary tissue inhibitor of metalloproteinase-2 and insulin-like growth factor-binding protein 7 accurately predicts acute kidney injury in septic patients with or without other organ failures.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ccm.0000000000001827","type":"journal-article","created":{"date-parts":[[2016,7,14]],"date-time":"2016-07-14T14:54:35Z","timestamp":1468508075000},"page":"1851-1860","source":"Crossref","is-referenced-by-count":102,"title":["Urinary Tissue Inhibitor of Metalloproteinase-2 and Insulin-Like Growth Factor-Binding Protein 7 for Risk Stratification of Acute Kidney Injury in Patients With Sepsis"],"prefix":"10.1097","volume":"44","author":[{"given":"Patrick M.","family":"Honore","sequence":"first","affiliation":[{"name":"Department of Intensive Care Medicine, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, VUB School of Medicine, Brussels, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Bryant","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Medicine, Pulmonary and Critical Care Medicine and Department of Emergency Medicine, Loma Linda University, Loma Linda, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Gong","sequence":"additional","affiliation":[{"name":"Division of Critical Care Medicine, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakhmir S.","family":"Chawla","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Intensive Care Medicine and Division of Nephrology, Veterans Affairs Medical Center, and Department of Anesthesiology and Critical Care Medicine, George Washington University Medical Center, Washington, DC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean M.","family":"Bagshaw","sequence":"additional","affiliation":[{"name":"Division of Critical Care Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Artigas","sequence":"additional","affiliation":[{"name":"Critical Care Center, Sabadell Hospital, CIBER de Enfermedades Respiratorias, Corporac\u00f3 Sanitaria Universitaria Parc Tauli, Autonomous University of Barcelona, Sabadell, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Shi","sequence":"additional","affiliation":[{"name":"Walker Biosciences, Carlsbad, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Joannes-Boyau","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Critical Care Medicine 2, Hospital Haut Leveque, University of Bordeaux 2, Bordeaux, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Vincent","sequence":"additional","affiliation":[{"name":"Department of Intensive Care, Erasme University Hospital, Universit\u00e9 Libre de Bruxelles, Brussels, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Kellum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230728","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/ki.2009.502","article-title":"Acute kidney injury in non-severe pneumonia is associated with an increased immune response and lower survival.","volume":"77","author":"Murugan","year":"2010","journal-title":"Kidney Int"},{"key":"R2-20230728","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2215\/CJN.03681106","article-title":"Septic acute kidney injury in critically ill patients: Clinical characteristics and outcomes.","volume":"2","author":"Bagshaw","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"R3-20230728","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00134-010-2089-9","article-title":"Sepsis as a cause and consequence of acute kidney injury: Program to Improve Care in Acute Renal Disease.","volume":"37","author":"Mehta","year":"2011","journal-title":"Intensive Care Med"},{"key":"R4-20230728","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.semnephrol.2015.01.003","article-title":"Clinical approach to the patient with AKI and sepsis.","volume":"35","author":"Godin","year":"2015","journal-title":"Semin Nephrol"},{"key":"R5-20230728","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1164\/rccm.201502-0307UP","article-title":"Update in sepsis and acute kidney injury in 2014.","volume":"191","author":"Schortgen","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"R6-20230728","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.semnephrol.2015.01.002","article-title":"Sepsis-associated acute kidney injury.","volume":"35","author":"Alobaidi","year":"2015","journal-title":"Semin Nephrol"},{"key":"R7-20230728","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/2110-5820-1-32","article-title":"Septic AKI in ICU patients. diagnosis, pathophysiology, and treatment type, dosing, and timing: A comprehensive review of recent and future developments.","volume":"1","author":"Honore","year":"2011","journal-title":"Ann Intensive Care"},{"key":"R8-20230728","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s10157-014-1076-9","article-title":"Acute kidney injury in septic patients admitted to emergency clinical room: Risk factors and outcome.","volume":"19","author":"Medeiros","year":"2015","journal-title":"Clin Exp Nephrol"},{"key":"R9-20230728","doi-asserted-by":"crossref","first-page":"544","DOI":"10.4103\/1319-2442.132171","article-title":"Outcome of patients with acute kidney injury in severe sepsis and septic shock treated with early goal-directed therapy in an intensive care unit.","volume":"25","author":"Ahmed","year":"2014","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"R10-20230728","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/ki.2013.374","article-title":"Potential use of biomarkers in acute kidney injury: Report and summary of recommendations from the 10th Acute Dialysis Quality Initiative consensus conference.","volume":"85","author":"Murray","year":"2014","journal-title":"Kidney Int"},{"key":"R11-20230728","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/nrneph.2012.197","article-title":"Subclinical AKI\u2013an emerging syndrome with important consequences.","volume":"8","author":"Haase","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"R12-20230728","first-page":"1","article-title":"KDIGO clinical practice guideline for acute kidney injury.","volume":"17","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"R13-20230728","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/ki.2009.224","article-title":"The cell cycle and acute kidney injury.","volume":"76","author":"Price","year":"2009","journal-title":"Kidney Int"},{"key":"R14-20230728","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2004.04.032","article-title":"Molecular events associated with reactive oxygen species and cell cycle progression in mammalian cells.","volume":"337","author":"Boonstra","year":"2004","journal-title":"Gene"},{"key":"R15-20230728","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1074\/jbc.M509932200","article-title":"Shp-1 mediates the antiproliferative activity of tissue inhibitor of metalloproteinase-2 in human microvascular endothelial cells.","volume":"281","author":"Seo","year":"2006","journal-title":"J Biol Chem"},{"key":"R16-20230728","doi-asserted-by":"crossref","first-page":"7475","DOI":"10.1093\/nar\/gkm744","article-title":"Two faces of p53: Aging and tumor suppression.","volume":"35","author":"Rodier","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"R17-20230728","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jinf.2009.04.003","article-title":"Acute renal failure during sepsis: Potential role of cell cycle regulation.","volume":"58","author":"Yang","year":"2009","journal-title":"J Infect"},{"key":"R18-20230728","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0092-8674(03)00551-8","article-title":"TIMP-2 mediated inhibition of angiogenesis: An MMP-independent mechanism.","volume":"114","author":"Seo","year":"2003","journal-title":"Cell"},{"key":"R19-20230728","first-page":"17","article-title":"Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury.","volume":"6","author":"Kashani","year":"2013","journal-title":"Crit Care"},{"key":"R20-20230728","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1164\/rccm.201401-0077OC","article-title":"Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication.","volume":"189","author":"Bihorac","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"R21-20230728","doi-asserted-by":"crossref","first-page":"e93460","DOI":"10.1371\/journal.pone.0093460","article-title":"Urinary TIMP-2 and IGFBP7 as early biomarkers of acute kidney injury and renal recovery following cardiac surgery.","volume":"9","author":"Meersch","year":"2014","journal-title":"PloS One"},{"key":"R22-20230728","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1213\/ANE.0000000000000243","article-title":"The urine protein NGAL predicts renal replacement therapy, but not acute kidney injury or 90-day mortality in critically ill adult patients.","volume":"119","author":"Nisula","year":"2014","journal-title":"Anesth Analg"},{"key":"R23-20230728","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.3109\/0886022X.2014.949764","article-title":"Urinary netrin-1 and KIM-1 as early biomarkers for septic acute kidney injury.","volume":"36","author":"Tu","year":"2014","journal-title":"Ren Fail"},{"key":"R24-20230728","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1093\/ndt\/gfu292","article-title":"Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers.","volume":"29","author":"Hoste","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"R25-20230728","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1097\/01.CCM.0000168253.91200.83","article-title":"The international sepsis forum consensus conference on definitions of infection in the intensive care unit.","volume":"33","author":"Calandra","year":"2005","journal-title":"Crit Care Med"},{"key":"R26-20230728","doi-asserted-by":"crossref","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies.","volume":"147","author":"von Elm","year":"2007","journal-title":"Ann Intern Med"},{"key":"R27-20230728","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S1076-6332(03)80086-7","article-title":"Toward complete and accurate reporting of studies of diagnostic accuracy: The STARD initiative.","volume":"10","author":"Bossuyt","year":"2003","journal-title":"Acad Radiol"},{"key":"R28-20230728","first-page":"673","article-title":"The value of commercial funding in health services research: The case of the APACHE III methodology.","volume":"28","author":"Knaus","year":"1994","journal-title":"Health Serv Res"},{"key":"R29-20230728","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/BF01709751","article-title":"The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine.","volume":"22","author":"Vincent","year":"1996","journal-title":"Intensive Care Med"},{"key":"R30-20230728","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1111\/j.0006-341X.2001.00963.x","article-title":"On small-sample confidence intervals for parameters in discrete distributions.","volume":"57","author":"Agresti","year":"2001","journal-title":"Biometrics"},{"key":"R32-20230728","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1164\/rccm.201505-0995OC","article-title":"The effects of alternative resuscitation strategies on acute kidney injury in patients with septic shock.","volume":"193","author":"Kellum","year":"2015","journal-title":"Am J Resp Crit Care Med"},{"key":"R33-20230728","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1053\/j.ajkd.2013.11.027","article-title":"Alkaline phosphatase: A possible treatment for sepsis-associated acute kidney injury in critically ill patients.","volume":"63","author":"Peters","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"R34-20230728","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000333837","article-title":"New insights regarding rationale, therapeutic target and dose of hemofiltration and hybrid therapies in septic acute kidney injury.","volume":"33","author":"Honor\u00e9","year":"2012","journal-title":"Blood Purif"},{"key":"R35-20230728","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s00134-015-3934-7","article-title":"Epidemiology of acute kidney injury in critically ill patients: The multinational AKI-EPI study.","volume":"41","author":"Hoste","year":"2015","journal-title":"Intensive Care Med"},{"key":"R36-20230728","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1007\/s00134-010-1887-4","article-title":"Neutrophil gelatinase-associated lipocalin in adult septic patients with and without acute kidney injury.","volume":"36","author":"M\u00e5rtensson","year":"2010","journal-title":"Intensive Care Med"},{"key":"R37-20230728","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1681\/ASN.2005030236","article-title":"Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit.","volume":"16","author":"Parikh","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R38-20230728","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s13054-015-0941-6","article-title":"Diagnostic value of neutrophil gelatinase-associated lipocalin, cystatin C, and soluble triggering receptor expressed on myeloid cells-1 in critically ill patients with sepsis-associated acute kidney injury.","volume":"19","author":"Dai","year":"2015","journal-title":"Crit Care"},{"key":"R39-20230728","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1097\/CCM.0000000000001079","article-title":"A multibiomarker-based model for estimating the risk of septic acute kidney injury.","volume":"43","author":"Wong","year":"2015","journal-title":"Crit Care Med"},{"key":"R40-20230728","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s00134-007-0656-5","article-title":"Urinary biomarkers in septic acute kidney injury.","volume":"33","author":"Bagshaw","year":"2007","journal-title":"Intensive Care Med"},{"key":"R41-20230728","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/2110-5820-2-24","article-title":"Biomarkers for early diagnosis of AKI in the ICU: Ready for prime time use at the bedside?","volume":"2","author":"Honore","year":"2012","journal-title":"Ann Intensive Care"},{"issue":"Suppl 2","key":"R42-20230728","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1179\/acb.2007.072","article-title":"Acute kidney injury in the ICU: Time has come for an early biomarker kit!","volume":"62","author":"Honore","year":"2007","journal-title":"Acta Clin Belg"},{"key":"R43-20230728","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1001\/jama.2015.4189","article-title":"Effect of remote ischemic preconditioning on kidney injury among high-risk patients undergoing cardiac surgery: A randomized clinical trial.","volume":"313","author":"Zarbock","year":"2015","journal-title":"JAMA"},{"key":"R44-20230728","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s00432-012-1153-y","article-title":"IGFBP-rP1 induces p21 expression through a p53-independent pathway, leading to cellular senescence of MCF-7 breast cancer cells.","volume":"138","author":"Zuo","year":"2012","journal-title":"J Cancer Res Clin Oncol"},{"key":"R45-20230728","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.cell.2007.12.032","article-title":"Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7.","volume":"132","author":"Wajapeyee","year":"2008","journal-title":"Cell"},{"key":"R46-20230728","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1093\/ndt\/gft101","article-title":"\u2018Biologic memory\u2019 in response to acute kidney injury: Cytoresistance, toll-like receptor hyper-responsiveness and the onset of progressive renal disease.","volume":"28","author":"Zager","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"R47-20230728","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.cyto.2015.02.013","article-title":"Evaluation of endothelial biomarkers as predictors of organ failures in septic shock patients.","volume":"73","author":"Palud","year":"2015","journal-title":"Cytokine"},{"key":"R48-20230728","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s00134-015-4026-4","article-title":"Does this patient have acute kidney injury? An AKI checklist.","volume":"42","author":"Kellum","year":"2015","journal-title":"Intensive Care Med"},{"key":"R49-20230728","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/S0140-6736(15)60266-5","article-title":"Automated, electronic alerts for acute kidney injury: A single-blind, parallel-group, randomised controlled trial.","volume":"385","author":"Wilson","year":"2015","journal-title":"Lancet"}],"container-title":["Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003246-201610000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T07:24:04Z","timestamp":1690529044000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003246-201610000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":48,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/ccm.0000000000001827","relation":{},"ISSN":["0090-3493"],"issn-type":[{"value":"0090-3493","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]}}}